KIM
BIIB icon

Kestra Investment Management’s Biogen BIIB Stock Holding History

Kestra Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62
Closed -$8.48K – 761
2025
Q1 		$8.48K Sell
62
-48
-44% -$6.86K ﹤0.01% 636
2024
Q4 		$16.8K Buy
+110
New +$18.6K ﹤0.01% 749

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Investment Management's BIIB Position: Q2 2025 in Review

Kestra Investment Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 62 shares — an estimated $8.48K sold.

Kestra Investment Management first reported a position in BIIB in Q4 2024 and held it in 2 quarters. The position peaked at $16.8K in Q4 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Kestra Investment Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Kestra Investment Management sold 62 Biogen shares in Q2 2025, an estimated $8.48K.
  • Kestra Investment Management first reported a position in Biogen in Q4 2024 and held it in 2 quarters.
  • Kestra Investment Management's Biogen position peaked at $16.8K in Q4 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Kestra Investment Management's 13F filing for Q2 2025, filed 15 Aug 2025.